Archives
-
Rimonabant (SR141716) in CB1 Research
2026-08-29
Rimonabant (SR141716) gives researchers a selective way to test whether appetite, inflammatory, or pain-related phenotypes depend on CB1 signaling. This practical guide combines formulation, receptor, cellular, behavioral, and cross-pathway workflows with troubleshooting strategies for cleaner interpretation.
-
CD28–ARS2–PKM Splicing in CD8+ T Cells
2026-08-28
Holling and colleagues identify a CD28–ARS2 signaling axis that reshapes PKM alternative splicing and gives activated CD8+ T cells greater flexibility in glucose metabolism. The study connects post-transcriptional RNA regulation with interferon-γ production and antitumor function, while showing that this metabolic branch is distinct from canonical CD28–PI3K signaling.
-
SETD7 Depletion Promotes White Adipose Browning
2026-08-28
The reference study identifies SETD7 as a negative regulator of thermogenesis in inguinal white adipose tissue rather than a general controller of adipocyte formation. Genetic SETD7 depletion enhanced beige-fat activity through an Adcy7–Sirt1–Creb1 pathway and improved energy expenditure and metabolic health in obese mice.
-
Prednisone Assays: From Mechanism to Measurement
2026-08-27
Prednisone is a synthetic corticosteroid whose effects on G1 arrest, IL-2 signaling, and lymphocyte apoptosis can be studied through a transformation-aware assay strategy. This guide connects immunology workflow design with LC–MS/MS lessons from recent botanical research without confusing digestive stability with corticosteroid pharmacology.
-
Angiotensin II: Applied Research Workflow Guide
2026-08-27
Build reproducible cell and animal studies with Angiotensin II, from GPCR-proximal signaling and vascular smooth muscle cell hypertrophy to pressure, vascular reactivity, remodeling, and renal injury endpoints. A reference-grounded workflow also shows how metabolomics-informed interventions can be evaluated without confusing disease-model improvement with direct peptide performance.
-
Psora 4: Practical Kv1.3 Blocker Workflows
2026-08-26
Psora 4 gives immune researchers a selective way to probe Kv1.3-dependent membrane potential, Ca2+ entry, and effector-memory T-cell activity. This workflow-focused guide covers stock preparation, kinetic assay design, cell-state controls, anti-GBM model interpretation, and troubleshooting.
-
Fluoxetine HCl: Reproducible Cell Assays
2026-08-26
A scenario-driven guide to using Fluoxetine HCl (SKU A2436) in serotonergic signaling, receptor, proliferation, and cytotoxicity workflows. It explains solvent control, dose interpretation, storage, assay compatibility, and vendor-selection criteria for more reproducible neuroscience research.
-
BGJ398 in FGFR Signaling Research
2026-08-25
BGJ398 (NVP-BGJ398) combines nanomolar FGFR1/2/3 potency with a practical workflow for validating FGFR dependence in cancer models. This guide connects target engagement, viability and apoptosis assays with a carefully bounded developmental-biology application inspired by recent Fgfr2 research.
-
Tacrine Hydrochloride Hydrate in Translational AD Research
2026-08-25
A mechanistic and strategic guide to using Tacrine hydrochloride hydrate as a cholinesterase probe, neuroprotection tool, and scaffold for multi-target Alzheimer’s disease research.
-
(-)-Norepinephrine (+)-bitartrate Workflow
2026-08-24
Build reproducible adrenergic assays with (-)-Norepinephrine (+)-bitartrate, from fresh solution preparation to renal perfusion and cardiomyopathy models. The workflow emphasizes receptor-aware controls, matched cardiovascular readouts, and troubleshooting for variable vasoconstrictor responses.
-
RIG-I, c-Myc, and Renal Fibrosis in UUO Mice
2026-08-24
The reference study identifies RIG-I as an injury-induced amplifier of renal tubulointerstitial fibrosis rather than only an antiviral RNA sensor. Using UUO and folic acid injury models, cell-based experiments, and human kidney samples, the authors connect tubular NF-κB–dependent cytokine release with c-Myc-driven TGF-β/Smad activation in fibroblasts.
-
H-89 and the Translational Logic of PKA Inhibition
2026-08-23
H-89 is a practical chemical probe for testing how PKA connects cAMP signaling with O-GlcNAcylation, glycolytic remodeling, osteoblast differentiation, and disease-relevant phenotypes. This thought-leadership guide translates mechanistic findings from Wnt-driven bone formation into rigorous assay design, interpretation, and translational strategy.
-
Fluoxetine HCl: Assay Workflows for Serotonin Biology
2026-08-22
Build reproducible Fluoxetine HCl workflows that connect transporter activity, 5HT2C signaling, membrane physiology, and reward behavior. This guide emphasizes formulation control, endpoint-specific concentration design, and practical interpretation of developmental SSRI findings.
-
Aminopeptidase Selectivity of ACE Inhibitors
2026-08-22
The reference study directly compared inhibitor profiles across three porcine kidney cell-surface zinc aminopeptidases, revealing substantial differences among AP-A, AP-N, and AP-W selectivity. Its finding that several carboxyalkyl and phosphoryl ACE inhibitors spared these aminopeptidases, whereas selected sulfhydryl compounds inhibited AP-W, provides an important framework for interpreting ACE-inhibitor experiments and off-target effects.
-
Angiotensin I/II (1-5) Workflow Guide
2026-08-21
Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research, including blood pressure regulation and aldosterone-related assays. It is suited to cardiovascular and renal workflows, but should not be treated as interchangeable with full-length angiotensin peptides or used in unrelated signaling studies without independent validation.